Expert Safety Testing to Accelerate Your Cell Therapy Development
May 11, 2012 - Charles River's unique portfolio of services, including discovery, preclinical, biopharmaceutical testing, cell detection methods, specialized and unique models, and regulatory guidance, provides the full spectrum of resources needed to conduct a successful cell therapy safety program.
Custom Study Designs
Charles River assists clients in developing cellular therapies using a strategic and consultative approach. With great consideration given to regulatory expectations, our customized cellular therapy programs integrate both safety and efficacy endpoints as well as mitigate risk factors inherent to developing novel cellular therapies. In the design of your program, our multidisciplinary team will incorporate the novel properties of your cellular product, including considerations of cross-species reactivity, animal model selection and development of validated translational biomarkers.
For more information about how Charles River can support and accelerate your cell therapy development, please contact us at email@example.com.
For more information, contact us at:
*indicates a required field.
The information you provided will be kept confidential.
We have established an in vivo screening platform to provide fast and cost-effective screening of compound effects on motor behavior and brain functionality for the study for central nervous system diseases.
We offer a package of well-established, state of the art in vitro mode of action assays that are suitable for early phase biocomparability studies, lot release and stability. These tests can accelerate the time it takes to get a new product ready for market submission.
May 28–Jun 01
The International Bone and Mineral Society (IBMS) and the Japanese Society for Bone and Mineral Research (JSBMR) are excited to sponsor the second joint scientific meeting by the two organizations.
May 23–May 23
This full-day seminar encompasses selected topics from our Charles River Short Course on Laboratory Animal Science. We would like to acknowledge Michigan State University for hosting this event and extend our heartfelt thanks to guest speaker Dr. Danielle Ferguson.
This position is responsible for serving as a as a study director (SD), project scientist (PS) and/or principal investigator (PI) in the direction and execution of assigned studies in compliance with GLP regulations as they apply to the conduct of nonclinical research; coordinating all phases of the study planning process with appropriate departments; generating high-quality project plans, protocols, amendments and reports appropriate for assigned studies; reviewing, interpreting, integrating and presenting data on assigned studies; and functioning as contact for the planning and execution of sponsor interaction related to assigned studies, including proposal management and study scheduling, conduct and reporting.
This position is responsible for managing international aspects of US Federal income tax compliance; assisting with international tax planning, including identification of planning opportunities, designing and implementing plans, and transfer pricing process; overseeing quarterly ETR forecast process; and participating in the tax provision process, including assessment of tax risks, documentation of key positions, and review of non-US tax provision submissions.
Charles River Laboratories, Inc.